Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.13 USD | +6.53% | +4.14% | +136.80% |
May. 15 | Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Cullinan Therapeutics, Inc. Announces Board Changes | CI |
Business Summary
Number of employees: 85
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-02-27 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 22-08-14 |
Chief Tech/Sci/R&D Officer | 57 | 17-12-31 | |
Kevin Johnston
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Chad Messer
IRC | Investor Relations Contact | - | 22-02-28 |
Corinne Savill
PRN | Corporate Officer/Principal | 64 | 17-01-31 |
Stephen Andre
HRO | Human Resources Officer | 62 | 22-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 17-07-31 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 17-07-31 |
Stephen Webster
BRD | Director/Board Member | 63 | 20-08-31 |
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Director/Board Member | 52 | 22-02-27 | |
David Ryan
BRD | Director/Board Member | 57 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,634,234 | 54,879,379 ( 95.22 %) | 0 | 95.22 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+136.80% | 1.39B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- CGEM Stock
- Company Cullinan Therapeutics, Inc.